As above mentioned, up to 50% of EGFR-amplified glioblastomas express the EGFRvIII variant: this mutant variant results in a 287-amino acid in frame deletion of exons 2–7 in the EGFR extracellular domain. This evidence concerns the gene EGFR and glioblastoma.